Abstract | OBJECTIVE: METHODS: RESULTS: No significant change of plasma SOD and LPO was found in the control group after treatment (P >0.05), while the plasma SOD activity increased and LPO content lowered in the treatment group significantly (P<0.01). Moreover, mRNA expression of MnSOD in the treatment group after treatment was obviously higher than that in the control group (P <0.01). CONCLUSIONS: The acting mechanism of BHQD for AP-CHD treatment might partially due to its effects in inducing gene expression of MnSOD in mononuclear cells, enhancing SOD activity, decreasing LPO content, maintaining oxidation/antioxidation equilibrium in myocardial cells, blocking the chain reaction of lipid peroxidation, intervening the production and enhancing the scavenging of oxygen free radicals.
|
Authors | Ling-Yun Yan, Yu-Quan Zhang, Xi-Mei Wang |
Journal | Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine
(Zhongguo Zhong Xi Yi Jie He Za Zhi)
Vol. 29
Issue 8
Pg. 695-7
(Aug 2009)
ISSN: 1003-5370 [Print] China |
PMID | 19848199
(Publication Type: English Abstract, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Drugs, Chinese Herbal
- Lipid Peroxides
- Superoxide Dismutase
|
Topics |
- Aged
- Angina Pectoris
(drug therapy, metabolism)
- Coronary Disease
(drug therapy, metabolism)
- Drugs, Chinese Herbal
(pharmacology, therapeutic use)
- Female
- Humans
- Lipid Peroxidation
- Lipid Peroxides
(blood)
- Male
- Middle Aged
- Oxidative Stress
- Phytotherapy
- Superoxide Dismutase
(metabolism)
|